ReachRxResearch
Home
Research
Sign Up
A caution in interpreting reliable cognitive decline in older adults at risk for Alzheimer’s disease
Back to Research Hub
  1. Home
  2. Research Hub
  3. A caution in interpreting reliable cogni…

A caution in interpreting reliable cognitive decline in older adults at risk for Alzheimer’s disease

International Psychogeriatrics·September 17Open Access
Psychology, ClinicalSafety signalAlzheimer'S DiseaseMild Cognitive ImpairmentSecondary Analysis Of Clinical Trial DataCognitive ScreeningOlder AdultAmyloid PET Imaging

Summary

View source

What was studied

This study compared two methods for detecting reliable cognitive decline — classical test theory (CTT) and item response theory (IRT) Reliable Change Indices (RCIs) — in 1,136 cognitively unimpaired older adults with elevated brain amyloid enrolled in the A4 clinical trial.

Key findings

While CTT- and IRT-based RCIs were strongly correlated overall (r = .83), among the 92 participants flagged as declining by at least one method, 44 (47.8%) received discordant classifications — meaning nearly half were labeled differently depending on which method was used.

Study limitations

- Sample limited to cognitively unimpaired, amyloid-positive older adults, reducing generalizability to broader populations. - Only the MMSE was used, a tool with known ceiling effects; findings may not extend to other screening instruments. - No gold-standard outcome (e.g., clinical progression) was used to determine which RCI method was more accurate.

Clinical implications

Clinicians using repeated MMSE screening to detect early cognitive decline should be aware that CTT-based RCIs may misclassify nearly half of individuals near the ceiling — consider IRT-based methods or instruments with better precision in high-functioning older adults.

Caveats

  • The paper is dated September 17, 2026, which is very recent; it may not yet have undergone broad peer scrutiny or citation validation.
  • The 'safety_signal' impact flag reflects the clinically important rate of misclassification (47.8% discordance), not a drug safety finding.
  • The study design is a secondary analysis of the A4 trial; causality and method superiority cannot be established without a clinical gold standard.

Related Questions

Explore related topics

What are the best cognitive screening tools for detecting early Alzheimer's decline in high-functioning older adults?How does item response theory improve measurement of cognitive change compared to classical test theory?What are the limitations of the MMSE for longitudinal cognitive monitoring in preclinical Alzheimer's disease?

Publication Details

Year
2026
Journal
International Psychogeriatrics
Sample Size
n=1,136
Source
View article
Keep scrolling
More content below.
Up Next